Welcome to LookChem.com Sign In|Join Free

CAS

  • or

76509-17-6

Post Buying Request

76509-17-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

76509-17-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 76509-17-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,5,0 and 9 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 76509-17:
(7*7)+(6*6)+(5*5)+(4*0)+(3*9)+(2*1)+(1*7)=146
146 % 10 = 6
So 76509-17-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H11NO/c1-2-5-11(6-3-1)10-14-12-7-4-8-13-9-12/h1-9H,10H2

76509-17-6Relevant articles and documents

Regioselective Single Electron Transfer Photocatalytic Synthesis of 2-Cyano-3-Ethylidenepiperidines. New Route to the Total Synthesis of (+/-) cis-Eburnamonine

Goes, Alexandre Da Silva,Ferroud, Clotilde,Santamaria, Jean

, p. 2235 - 2238 (1995)

A new synthesis of (+/-) cis-eburnamonine is described through a tetracyclic intermediate 3 obtained from 2-cyano-3-ethylidenepiperidines generated in situ by a regioselective single electron transfer (SET) photocatalysis.

Novel protein kinase inhibitors related to tau pathology modulate tau protein-self interaction using a luciferase complementation assay

Holzer, Max,Schade, Nico,Opitz, Ansgar,Hilbrich, Isabel,Stieler, Jens,Vogel, Tim,Neukel, Valentina,Oberstadt, Moritz,Totzke, Frank,Schchtele, Christoph,Sippl, Wolfgang,Hilgeroth, Andreas

, (2018/09/26)

The current number of drugs available for the treatment of Alzheimer's disease (AD) is strongly limited and their benefit for therapy is given only in the early state of the disease. An effective therapy should affect those processes which mainly contribu

First biological evaluation of developed 3-benzyloxyfluorenes as novel class of MDR modulators

Krug, Martin,Voigt, Burkhardt,Baumert, Christiane,Lüpken, Ralf,Molnár, Joséf,Hilgeroth, Andreas

experimental part, p. 2683 - 2688 (2010/07/09)

A series of 3-benzyloxy-1-aza-9-oxafluorenes has been synthesized and biologically evaluated as novel MDR modulators. The concentration dependent inhibition of the efflux pump ABCB1 (P-glycoprotein) has been characterized and is discussed in relation to calculated lipophilicity data. Instead of the molecular lipophilicity the exact positioning of functional groups was found decisive for the biological activities.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 76509-17-6